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I N T R O D U C T I O N
Cystic fibrosis is caused by genetic mutations that dis-
rupt the function of the CFTR, an anion channel ex-
pressed predominantly in epithelial cells (Rowe et al., 
2005). CFTR is a member of the ATP-binding cassette 
(ABC) family of membrane transport proteins, but is 
unique within this family in acting as an ion channel 
rather than an active transporter (Gadsby et al., 2006). 
As with other ABC proteins, CFTR has a modular archi-
tecture consisting of two groups of six transmembrane 
(TM)  helices, each followed by a cytoplasmic nucleo-
tide–binding domain. In CFTR, these two homologous 
halves of the molecule are connected by a unique cyto-
plasmic regulatory domain. The TMs, nucleotide bind-
ing, and regulatory domains are the sites of TM anion 
movement, control of channel gating by intracellular 
ATP, and channel regulation by phosphorylation and 
dephosphorylation,  respectively  (Kidd  et  al.,  2004; 
Gadsby et al., 2006).
To understand CFTR’s role as an anion channel, it is 
important to understand the structure and function of 
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the TM permeation pathway through which anions 
move. Indeed, the CFTR pore region has been investi-
gated using a combination of imaging (Mio et al., 2008; 
Zhang et al., 2009), functional (Kidd et al., 2004; Linsdell, 
2006), and molecular modeling (Mornon et al., 2008; 
Serohijos et al., 2008; Alexander et al., 2009) studies. 
Functional  evidence  suggests  that  individual  TM  re-
gions 1, 5, 6, 11, and 12 all make some contribution to 
the lining of the pore (McCarty, 2000; St. Aubin and 
Linsdell,  2006;  Linsdell,  2006;  Mornon  et  al.,  2008; 
Fatehi and Linsdell, 2009; Zhou et al., 2010), with TMs 1 
and 6 being particularly important to the functional 
properties of the central/outer part of the pore (Ge et al., 
2004). The relative positions of different TMs can be 
observed in atomic models of the CFTR protein that are 
based on homology modeling of the bacterial ABC pro-
tein Sav1866 (Mornon et al., 2008; Serohijos et al., 
2008). However, there is little functional or direct imag-
ing  evidence  to  support  the  overall  arrangement  or 
alignment of the TMs around the pore, although lim-
ited TM cross-linking experiments have been used to 
demonstrate physical proximity of specific amino acid 
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y166 Three-dimensional organization of the CFTR pore
expression in the cell membrane (Li et al., 2009). In this back-
ground (referred to as “cys-less CFTR”), we have mutated indi-
vidually  21  consecutive  amino  acids  in  TM1,  from  Y84  at  the 
putative cytoplasmic end to R104 at the extracellular end, to cys-
teine. Mutagenesis was performed using the QuikChange site- 
directed mutagenesis system (Agilent Technologies) and verified 
by DNA sequencing. All constructs used were in the pIRES2-EGFP 
vector (Li et al., 2009), allowing coexpression of CFTR with en-
hanced  green  fluorescent  protein.  BHK  cells  were  transiently 
transfected as described previously (Gong et al., 2002), except 
that 24 h after transfection, cells were transferred to 27°C to pro-
mote mature protein expression (Li et al., 2009). Cells were used 
for electrophysiological experimentation after 1–3 d at 27°C. In-
dividual cells were selected for patch-clamp investigation based 
on identification of enhanced green fluorescent protein expres-
sion by fluorescence microscopy.
Macroscopic CFTR currents were recorded using patch-clamp 
recording from inside-out membrane patches excised from BHK 
cells as described in detail previously (Linsdell and Hanrahan, 
1996; Linsdell and Gong, 2002). After patch excision, any pre-
treatment of the inside-out patch if necessary (see below), and re-
cording of background currents, CFTR channels were activated 
by exposure to 20 nM PKA catalytic subunit plus 1 mM MgATP in 
the cytoplasmic solution. Unless stated otherwise, CFTR channel 
activity was then further increased by the addition of 2 mM of so-
dium pyrophosphate (PPi). PPi was used to maximize and stabi-
lize  macroscopic  current  amplitude,  which  was  very  small  for 
many TM1 mutants, and so increase resolution. Both intracellular 
(bath) and extracellular (pipette) solutions contained 150 mM 
NaCl, 2 mM MgCl2, and 10 mM N-tris(hydroxymethyl)methyl-2-
aminoethanesulfonate (pH adjusted to 7.4 using NaOH). Channels 
were exposed to intracellular and extracellular cysteine-reactive 
methanethiosulfonate (MTS) reagents to covalently modify intro-
duced  cysteine  side  chains.  Two  MTS  reagents,  the  positively 
charged [2-(trimethylammonium)ethyl] MTS (MTSET) and the 
negatively charged [2-sulfonatoethyl] MTS (MTSES), were used. 
These  reagents  were  initially  prepared  as  high  concentration 
(160-mM) stock solutions in distilled water and stored frozen as 
small-volume aliquots until the time of use, when they were di-
luted in bath solution and used immediately. The oxidizing agent 
copper(II)-o-phenanthroline  (CuPhe)  was  prepared  freshly   
before each experiment by mixing CuSO4 (200 mM in distilled 
water) with 1,10-phenanthroline (200 mM in ethanol) in a 1:4 
molar ratio, and used at a final concentration of 100 µM Cu
2+ and 
400 µM phenanthroline.
Initially high concentrations of MTS reagents (200 µM MTSES 
or 2 mM MTSET) that have previously been found to be without 
effect on cys-less CFTR currents (Li et al., 2009; El Hiani and 
Linsdell, 2010; Zhou et al., 2010) were applied to the cytoplasmic 
face of inside-out membrane patches after maximal channel acti-
vation, and currents were monitored for at least 5 min until the 
current had again reached a steady amplitude (see Fig. 1 A). To 
measure the rate of modification of open channels (see Fig. 3), 
macroscopic current amplitude was monitored continuously, and 
the time-dependent change in amplitude after the addition of 
MTSES was fitted by a single-exponential function. To ensure that 
differences in the modification rate between different MTS re-
agents did not reflect differences in the voltage dependence of 
MTS reagent entry into the pore, the membrane patch was held 
at 0-mV membrane potential, and current amplitude was moni-
tored during brief voltage deflections (see below for details of 
voltage-clamp protocols used). In cases where the rate of modifi-
cation was very fast, the concentration of MTS reagents used was 
reduced (to 20 µM MTSES or 200 µM MTSET). The time con-
stant of exponential current decay, , was used to calculate the ap-
parent second-order reaction rate constant, k, from the equation 
k = 1 / ([MTS] ).
residues in TMs 6 and 12 (Chen et al., 2004), TMs 6 and 7 
(Wang et al., 2007), and TMs 1 and 12 (Zhou et al., 
2010). As a result, current understanding of function-
ally important parts of the pore is limited to two-dimen-
sional  rather  than  three-dimensional  models.  For 
example, the narrow region of the pore that might form 
a “selectivity filter” that discriminates between Cl
 and 
other anions is thought to be lined by TM6 residues 
F337 and T338 (Linsdell, 2006), but residues from 
other TMs contributing to this region have not been 
identified. We recently suggested that TM6 residues 
I344 and V345 might be located around a “barrier” that 
prevents anion movement in nonactivated CFTR chan-
nels (El Hiani and Linsdell, 2010), but again, residues 
from other TMs that might contribute to such a barrier 
have not been identified. The outer mouth of the CFTR 
pore is thought to be decorated by positively charged 
amino acid side chains coming from different TM re-
gions or the short extracellular loops that connect the 
TMs (Zhou et al., 2008), but the relative location and 
depth into the pore from the outside of different posi-
tively charged side chains have not been reported.   
A further impediment to fully understanding the struc-
ture of the pore is that only one TM, TM6, has been 
probed using cysteine scanning mutagenesis and appli-
cation of cysteine-reactive probes to both the intracellu-
lar and extracellular side of the membrane (Cheung 
and Akabas, 1996; Beck et al., 2008; Alexander et al., 
2009;  Bai  et  al.,  2010;  El  Hiani  and  Linsdell,  2010),   
allowing the contribution of the entire length of this 
TM region to the pore to be ascertained.
We have studied the accessibility of amino acid resi-
dues in TM1, known to be functionally important in the 
CFTR pore (Akabas et al., 1994; Ge et al., 2004; Linsdell, 
2006),  to  substances  applied  from  either  side  of  the 
membrane. We find that cysteine-reactive substances 
have access to a restricted region in the outer part of 
TM1, depending on the side of the membrane to which 
they are applied. Comparison of the functional effects 
of modification of cysteines introduced into TM1 with 
those observed for cysteines in TM6 suggest a relative 
alignment of these two TMs, which we confirm using di-
sulfide cross-linking of cysteine side chains introduced 
into these two TMs. These results allow us to develop a 
functional model of the pore that incorporates three-
dimensional  information  relating  to  two  important 
pore-lining TMs.
M AT E R I A L S   A N D   M E T H O D S
Experiments were performed using baby hamster kidney (BHK) 
cells transiently transfected with human CFTR. As in our recent 
study on CFTR-TM6 (El Hiani and Linsdell, 2010), we have used 
a human CFTR variant in which all 18 endogenous cysteine resi-
dues had been substituted by other amino acids (as described   
in Mense et al., 2006), and which also includes a mutation in   
the first nucleotide-binding domain (V510A) to increase protein   Wang et al. 167
cross-linked residues in a current homology model of the CFTR 
membrane–spanning domain. Figs. S1–S3 are available at http://
www.jgp.org/cgi/content/full/jgp.201110605/DC1.
R E S U LT S
Accessibility of cysteines introduced into TM1
We (El Hiani and Linsdell, 2010) and others (Bai et al., 
2010) have recently used internal application of MTS re-
agents to identify pore-lining cysteine side chains intro-
duced into TM6 of cys-less CFTR. In the present study, 
we used a similar approach to identify pore-lining side 
chains in TM1. Using site-directed mutagenesis, we sub-
stituted cysteines for each of 21 consecutive amino acids, 
from Y84 near the putative intracellular end of TM1 to 
R104 near the extracellular end, in a V510A cys-less back-
ground (see Materials and methods). In most cases, ex-
pression  of  these  mutants  in  BHK  cells  led  to  the 
appearance of macroscopic PKA- and ATP-dependent 
currents in inside-out membrane patches (e.g., Figs. 1 
and S1). The one exception was E92C, which failed to 
generate any measureable current, even after multiple 
attempts  with  two  independently  constructed  mutant 
cDNAs. Substitution of E92 by other residues in a wild-
type  CFTR  background  also  fails  to  yield  functional 
channels in mammalian cells (unpublished data).
The application of negatively charged MTSES (200 µM) 
or positively charged MTSET (2 mM) to the intra-
cellular solution after channel activation with PKA, 
ATP, and PPi had no significant effect on macroscopic 
current amplitude in cys-less CFTR (Fig. 1, A and B), 
as reported previously (El Hiani and Linsdell, 2010;   
Zhou et al., 2010), although higher concentrations of 
MTSES do cause a reversible, voltage-dependent inhi-
bition under these conditions (Li et al., 2009). A simi-
lar lack of effect after prolonged (>5-min) exposure to 
such high concentrations of both MTSES and MTSET 
was observed in 16 out of 20 cysteine-substituted mu-
tants tested (Figs. 1 B, 2, and S1), suggesting that the 
side chains at these positions are not accessible to inter-
nal MTS reagents. This list of MTS reagent–insensitive 
mutants includes R104C (Figs. 1 B and 2), which we 
have previously shown to be sensitive to modification 
by externally applied MTSES and MTSET (Zhou et al., 
2008). In contrast, macroscopic currents carried by 
four mutants, K95C, Q98C, P99C, and L102C, were 
found to be significantly and rapidly sensitive to the   
application of both MTSES and MTSET (Figs. 1–3). In 
each  case,  macroscopic  current  amplitude  was  de-
creased by the application of MTSES but increased by 
MTSET (Figs. 1 and 2), a pattern also frequently ob-
served for cysteines introduced into TM6 (Bai et al., 
2010; El Hiani and Linsdell, 2010). These effects of 
MTS  reagents  were  not  reversed  by  washing  the  re-
agents from the bath (see also Fig. 5 C). However, as   
previously described for cysteines introduced into TM6 
In some cases, MTS reagents were used to pretreat intact cells 
(external application; Fig. 4) or inside-out membrane patches 
(internal application; Fig. 5) before recordings. In Fig. 4, chan-
nels were pretreated with external MTSET. Intact cells were pre-
incubated in 5 mM MTSET (in normal bath solution) for 5 min, 
after which cells were washed thoroughly with bath solution and 
transferred to the recording chamber for patch-clamp analysis. 
MTSET  was  used  in  these  experiments,  as  we  have  previously 
found it to be a less state-dependent probe of the outer pore than 
MTSES (Fatehi and Linsdell, 2008). Indeed, we have previously 
used a similar MTSET pretreatment protocol to identify positively 
several  externally  accessible  sites  in  CFTR  (Zhou  et  al.,  2008; 
Fatehi and Linsdell, 2009; El Hiani and Linsdell, 2010), including 
R104 at the external end of TM1 (Zhou et al., 2008).
In Fig. 5, channels were pretreated with internal MTSES, using 
one of two pretreatment protocols described previously (El Hiani 
and Linsdell, 2010). After patch excision to the inside-out config-
uration, 200 µM MTSES was added to the cytoplasmic (bath) so-
lution. MTSES was applied alone (for modification of nonactivated 
channels) (Fig. 5 B) or together with 20 nM PKA and 1 mM ATP 
(for modification of activated channels) (Fig. 5 A). After a 2-min 
treatment period, all substances were washed from the bath   
using normal bath solution. After recording of background leak 
currents, CFTR channels were then activated using 20 nM PKA,   
1 mM ATP, and 2 mM PPi, as usual, and then exposed to a test 
treatment of MTSES. Although this approach does not quantify 
the rate of modification of nonactivated channels, it does pro-
vide a simple separation of side chains that are readily modified 
in nonactivated channels versus those for which the rate of modi-
fication in nonactivated channels is negligible (see El Hiani and 
Linsdell, 2010). Pretreatment for 2 min with 200 µM MTSES is 
expected to result in 100% modification in fully activated chan-
nels (see Fig. 3 B). A similar approach was used to pretreat chan-
nels with CuPhe in Fig. 7; in these experiments, the degree of 
cross-linking induced by CuPhe during the pretreatment period 
was quantified by the effects of 5 mM dithiothreitol (DTT) ap-
plied after washing and subsequent channel activation with PKA 
and ATP.
For channel inhibition by Cu
2+ ions, concentration–inhibition 
relationships (Fig. 8 B) were fitted by an equation of the form:
   
Fractional unblocked current   1    1    Cu  
2
d = +     ( )
+ / / ), K
nH
 
where Kd is the apparent inhibitor dissociation constant, and nH 
is the slope factor or Hill coefficient.
Current traces were filtered at 100 Hz using an eight-pole   
Bessel filter, digitized at 250 Hz, and analyzed using pCLAMP-10 
software (Molecular Devices). Macroscopic I-V relationships were 
constructed using depolarizing ramp protocols (Linsdell and 
Hanrahan, 1998) from a holding potential of 0 mV. Background 
(leak) currents recorded before the addition of PKA and ATP 
have been subtracted digitally, leaving uncontaminated CFTR cur-
rents (Linsdell and Hanrahan, 1998; Gong and Linsdell, 2003).
Experiments were performed at room temperature (21–24°C). 
Values are presented as mean ± SEM. Tests of significance were 
performed using a Student’s two-tailed t test, unless stated other-
wise. All chemicals were from Sigma-Aldrich, except for PKA (Pro-
mega) and MTSES and MTSET (Toronto Research Chemicals).
Online supplemental material
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estimated from the time course of macroscopic current 
amplitude change after the application of MTSES (20–
200 µM) or MTSET (200 µM–2 mM). As shown in Fig. 3 A, 
MTSES modification was rapid in K95C, even when a 
low concentration of MTSES (20 µM) was used, and 
considerably slower in L102C (using 200 µM MTSES). 
The  overall  pattern  of  calculated  modification  rate 
(El Hiani and Linsdell, 2010), the effects of MTS re-
agents could be reversed by the addition of 2–5 mM 
DTT. The effects of MTS reagents on the amplitude of 
macroscopic currents carried by different channel con-
structs are summarized in Fig. 2.
For those four mutants that were sensitive to modifi-
cation by MTS reagents, the rate of modification was   
Figure 1.  Modification of cysteine-substituted CFTR-TM1 mutants by internal MTS reagents. (A) Example time courses of macroscopic 
currents (measured at +50 mV) carried by cys-less CFTR and Q98C inside-out membrane patches. After patch excision and recording 
of baseline currents, patches were treated sequentially with 20 nM PKA and 1 mM ATP, 2 mM PPi, and either 200 µM MTSES or 2 mM 
MTSET. Note that whereas these MTS reagents have no effect on cys-less CFTR current amplitude, they cause rapid inhibition (MTSES) 
or augmentation (MTSET) of current carried by Q98C. (B) Example leak-subtracted I-V relationships for cys-less CFTR, K95C, Q98C, 
P99C, L102C, and R104C, recorded from inside-out membrane patches after maximal channel activation with 20 nM PKA, 1 mM ATP, 
and 2 mM PPi. In each panel, currents recorded before the application of MTS reagents (control) and after full modification by 200 µM 
of intracellular MTSES or 2 mM MTSET had been achieved.  Wang et al. 169
MTSET. Using a similar approach to that used previ-
ously in TM6 (El Hiani and Linsdell, 2010), we sought 
to identify sites at which pretreatment with externally 
applied  MTSET  would  prevent  subsequent  modifica-
tion by internally applied MTSET. As described previ-
ously (El Hiani and Linsdell, 2010), intact cells were 
exposed to a high concentration of MTSET (5 mM) for 
5 min. Cells were then washed and transferred to the 
experimental chamber for patch-clamp analysis. After 
patch excision to the inside-out configuration, CFTR 
channels were activated using PKA, ATP, and PPi and 
subsequently treated with intracellular MTSET (2 mM), 
exactly as in Fig. 1. As shown in Fig. 4 A, patches excised 
from MTSET-pretreated cells expressing K95C, Q98C, 
P99C, or L102C all gave macroscopic currents that were 
increased  in  amplitude  after  the  addition  of  2  mM   
constants was that modification was faster for cysteines 
introduced closer to the intracellular end of TM1, and 
slower for cysteines located more deeply along the axis 
of TM1 (Fig. 3 B). This same pattern was observed both 
for  the  inhibition  of  current  amplitude  caused  by   
MTSES application and the increase in current ampli-
tude after MTSET application (Fig. 3 B). Interestingly, 
the  rate  of  modification  by  MTSET  was  consistently 
lower than that by MTSES, with the MTSET modifica-
tion rate constant being between 8- and 13-fold lower 
for all MTS-sensitive mutants studied (Fig. 3 B).
Side and state dependence of modification
MTS reagents are not permeant in CFTR (Beck et al., 
2008;  Alexander  et  al.,  2009;  El  Hiani  and  Linsdell, 
2010); however, we previously identified three sites in 
TM6 at which introduced cysteines could be modified 
by both internally and externally applied MTS reagents 
(El Hiani and Linsdell, 2010). To gain some informa-
tion on the orientation of TM1 in the CFTR pore, we 
therefore examined whether cysteines introduced into 
TM1 that were sensitive to modification by intracellular 
MTS reagents could also be modified by extracellular 
Figure  2.  Effects  of  internal  MTS  reagents  on  cysteine-substi-
tuted CFTR-TM1 mutants. Mean effect of treatment with 200 µM 
MTSES (left) or 2 mM MTSET (right) on macroscopic current 
amplitude in cys-less CFTR and in each of 20 different cysteine-
substituted TM1 mutants. Note that no currents were recorded 
from patches excised from cells transfected with E92C cDNA (see 
Results). Effects of these two MTS reagents were quantified by 
measuring current amplitudes at membrane potentials of +80 mV 
(for MTSES, left) and 80 mV (for MTSET, right) before MTS 
reagent application and after complete modification had taken 
place. Mean of data from three to nine patches. Asterisks indicate 
a significant difference from cys-less (P < 0.05).
Figure 3.  Time course of modification by MTSES and MTSET. 
(A) Example time courses of macroscopic currents (measured at 
50 mV during brief voltage excursions from a holding potential 
of 0 mV) carried by K95C (left) and L102C (right) as indicated, 
in inside-out membrane patches. Current amplitudes were mea-
sured every 6 s after the attainment of stable current amplitude   
after channel activation with 20 nM PKA, 1 mM ATP, and 2 mM 
PPi. In each case, MTSES (20 µM for K95C and 200 µM for L102C) 
was applied to the cytoplasmic face of the patch at time zero (as 
indicated by the hatched bar at the bottom of each panel). The 
decline in current amplitude after MTSES application has been 
fitted by a single-exponential function in each case. (B) Calculated 
modification rate constants for both MTSES () and MTSET () 
for each of the four MTS reagent–sensitive mutants listed. Aster-
isks indicate a significant difference from MTSES modification of 
K95C (P < 0.005), and daggers indicate a significant difference 
from MTSES modification of the same mutant (P < 0.05). Mean 
of data from three patches in each case is shown.170 Three-dimensional organization of the CFTR pore
shows the effects of MTSES application under similar 
conditions to those in Fig. 1, after maximal channel 
stimulation with PKA, ATP, and PPi, but in inside-out 
patches that had been pretreated with 200 µM of intra-
cellular  MTSES  (for  a  2-min  pretreatment  period)   
under  two  different  sets  of  pretreatment  conditions 
(see Materials and methods). In Fig. 5 A, patches were 
pretreated with MTSES in the presence of PKA and 
ATP after patch excision, whereas in Fig. 5 B, inside-
out patches were pretreated with MTSES alone. In this 
way,  we  expect  MTSES  applied  during  the  pretreat-
ment period to have access to activated channels in 
Fig. 5 A, but only to nonactivated channels in Fig. 5 B. 
In both cases, after the 2-min pretreatment period, all 
drugs  were  thoroughly  washed  from  the  bath,  and 
channels were activated by PKA, ATP, and PPi before 
the application of a second test exposure to MTSES. In 
patches that had been pretreated with MTSES, PKA, 
and ATP and then washed, currents carried by each of 
these four mutants were insensitive to the second test 
exposure to MTSES (Fig. 5 A), suggesting that chan-
nels had been covalently modified by MTSES during 
the pretreatment period, and that this modification 
had not been reversed by washing the MTSES from the 
bath. However, different results were obtained when 
patches were pretreated with MTSES in the absence of 
PKA and ATP. Whereas K95C channels were again ren-
dered insensitive to a test exposure to MTSES, again 
consistent with them having been covalently modified 
during pretreatment, currents carried by Q98C, P99C, 
MTSET to the intracellular solution. In fact, as shown 
quantitatively in Fig. 4 B, these currents showed indis-
tinguishable sensitivity to intracellular MTSET to those 
recorded from patches excised from cells that had not 
been pretreated with extracellular MTSET (see, for ex-
ample, Fig. 1). These results suggest that none of K95C, 
Q98C, P99C, or L102C can be modified covalently by 
extracellular MTSET.
Our  work  concerning  intracellular  MTS  reagent 
modification in TM6 also identified some cysteines 
that could be modified in both activated and nonacti-
vated channels (e.g., V345C and M348C), and others 
that could apparently be modified only after channel 
activation (e.g., T338C, S341C, and I344C), suggest-
ing  a  state-dependent  conformational  change  that   
alters access of internally applied MTS reagents into 
the pore (El Hiani and Linsdell, 2010). This difference 
was most readily apparent using a pretreatment proto-
col, in which cysteines introduced at some sites were 
modified by pretreatment of inside-out patches with 
intracellular MTSES, whereas others were apparently 
not modified unless the pretreatment also included 
PKA and ATP to promote channel activation (El Hiani 
and Linsdell, 2010). We used a similar approach to de-
termine if K95C, Q98C, P99C, and L102C could be 
modified by MTSES pretreatment. Each of these mu-
tants is rapidly modified by the application of 200 µM 
of intracellular MTSES applied after channel activa-
tion (Fig. 3), leading to a decrease in macroscopic 
current amplitude (Figs. 1 and 2). Fig. 5 (A and B) 
Figure  4.  Modification of in-
troduced cysteines by pretreat-
ment  with  external  MTSET. 
(A)  Example  leak-subtracted   
I-V relationships for each of the 
four MTSET-sensitive mutants 
named,  showing  the  effects 
of  the  application  of  internal 
MTSET (2 mM) after maximal 
channel activation with 20 nM 
PKA,  1  mM  ATP,  and  2  mM 
PPi. Patches were excised from 
cells that had been pretreated 
with external MTSET (5 mM 
for 5 min) and showed similar 
sensitivity  to  internal  MTSET 
as  patches  excised  from  un-
treated cells (see Fig. 1 B for 
examples). (B) Comparison of 
the effects of MTSET on mac-
roscopic current amplitude at 
80 mV between patches from 
untreated  cells  and  patches 
from cells pretreated with ex-
ternal MTSET. There were no 
statistically significant differ-
ences for any mutant studied 
(P > 0.05). Mean of data from 
three to nine patches is shown.  Wang et al. 171
Proximity and alignment of TMs 1 and 6
The results described in Fig. 5, suggesting that K95C is 
accessible to cytoplasmic MTSES in nonactivated chan-
nels but that Q98C is accessible only in activated chan-
nels, imply that K95 and Q98 may lie close to the putative 
barrier within the pore that we recently proposed to 
regulate access from the cytoplasmic solution (El Hiani 
and Linsdell, 2010). In TM6, I344 and V345 were pro-
posed to lie on either side of this barrier, based on similar 
and L102C were all strongly inhibited by the applica-
tion of the test dose of MTSES, suggesting that they 
were not covalently modified by MTSES pretreatment. 
These results, which are summarized quantitatively in 
Fig. 5 C, suggest that although K95C can be modified 
by MTSES before channel activation, Q98C, P99C, and 
L102C are modified by MTSES only very slowly, if at 
all, in channels that have not been activated by PKA 
and ATP.
Figure  5.  Modification  of  introduced  cysteines  during  pretreatment  with  internal  MTSES.  (A  and  B)  Example  leak-subtracted   
I-V relationships for each of the four MTSES-sensitive mutants named, showing the effects of the application of internal MTSES (200 µM) 
after maximal channel activation with 20 nM PKA, 1 mM ATP, and 2 mM PPi. Patches have been pretreated in two different ways (see 
Materials and methods): (A) pretreated with 200 µM MTSES, PKA, and ATP for 2 min; (B) pretreated with 200 µM MTSES alone for   
2 min. Similar examples for patches that underwent no pretreatment are shown in Fig. 1 B. Note that for each mutant, after pretreat-
ment with MTSES, PKA, and ATP, stimulated currents appeared refractory to the effects of internally applied MTSES (A), suggesting that 
channels had been covalently modified during the pretreatment. (C) Mean effect of internal MTSES on macroscopic current amplitude 
at +80 mV under three different sets of condition as indicated: no pretreatment (see Fig. 1 B); pretreated with MTSES, PKA, and ATP (A); 
and pretreated with MTSES alone (B). Asterisks indicate a significant difference from control (no pretreatment) conditions (P < 0.005); 
other groups not marked by an asterisk showed no significant difference from control conditions (P > 0.3). Mean of data from three to 
six patches is shown.172 Three-dimensional organization of the CFTR pore
(Fig. 3) (El Hiani and Linsdell, 2010) (see Discussion). 
We therefore speculated that K95 and Q98 in TM1 
might be located close to I344 and V345 in TM6 in the 
three-dimensional structure of the CFTR pore, perhaps 
being situated around a regulated barrier to ion move-
ment in nonactivated channels. To test this idea, we 
therefore  used  site-directed  mutagenesis  to  create 
apparent state-dependent changes in accessibility to 
intracellular MTSES (El Hiani and Linsdell, 2010). Fur-
thermore, the MTSES modification rate constants for 
cysteines introduced at these four sites (K95, Q98, I344, 
and V345) were similar, whereas those for cysteines in-
troduced closer to the outer ends of TM1 (P99 and 
L102) or TM6 (T338 and S341) were considerably lower 
Figure 6.  Cross-linking of TMs 1 and 6 by the oxidizing agent CuPhe. (A–C) Example leak-subtracted I-V relationships for K95C/I344C 
(A), Q98C/I344C (B), and Q98C/M348C (C) after channel activation with 20 nM PKA and 1 mM ATP. In A and B, current amplitude 
is decreased by the subsequent addition of CuPhe to the intracellular solution, whereas in C, CuPhe is without effect. In both CuPhe-
  sensitive channel constructs, the inhibitory effects of CuPhe were not reversed by washing CuPhe from the bath (top panels in both A and B), 
but were reversed by the addition of 5 mM DTT to the intracellular solution (bottom panels in both A and B). (D) Mean effect of inter-
nal CuPhe on macroscopic current amplitude under these conditions, measured at membrane potentials of 80 mV (white bars) and 
+80 mV (black bars). Note that cys-less CFTR, the single mutants K95C, Q98C, or I344C, and the double mutant Q98C/M348C were all 
insensitive to CuPhe under these conditions. Also note that CuPhe had a stronger inhibitory effect on currents carried by K95C/I344C 
when measured at +80 mV compared with 80 mV; this same apparent voltage dependence was previously reported for K95C/S1141C 
under similar experimental conditions (Zhou et al., 2010). In contrast, the inhibitory effects of CuPhe on Q98C/I344C were similar 
when measured at 80 mV or +80 mV. Asterisks indicate a significant difference from control: *, P < 0.005; **, P < 0.00005. (E) Mean   
effects of CuPhe (black bars), CuPhe followed by washing with normal bath solution (white bars), and CuPhe followed by DTT (gray bars) 
on macroscopic current amplitude in K95C/I344C (left) and Q98C/I344C (right) at +80 mV. Daggers indicate a significant difference 
from CuPhe alone (P < 0.005); washing alone (white bars) had no significant effect compared with CuPhe alone (P > 0.6). Mean of data 
from three to seven patches is shown in D and E.  Wang et al. 173
both K95C/I344C and Q98C/I344C by CuPhe was not 
reversed by washing CuPhe from the bath; however, par-
tial reversal was seen when 5 mM DTT was applied in 
the continued presence of CuPhe (Fig. 6, A, B, and E), 
consistent with CuPhe inhibition of these channels re-
flecting some oxidative process.
The results shown in Fig. 6 suggest that disulfide bond 
formation can occur between K95C and I344C and be-
tween Q98C and I344C after channel activation. To test 
whether these cysteines can also be cross-linked before 
channel activation, we used a CuPhe pretreatment pro-
tocol (Fig. 7). After patch excision, inside-out patches 
from cells expressing either K95C/I344C or Q98C/
I344C were treated with cytoplasmic CuPhe for 2 min, 
after which CuPhe was washed from the bath and cur-
rents were activated using PKA and ATP, as usual. Cur-
rents activated in this way appeared normal and were 
not sensitive to the application of 5 mM DTT (Fig. 7), 
suggesting that negligible disulfide bond formation   
had taken place during the CuPhe pretreatment period. 
This contrasts with the robust DTT sensitivity of chan-
nels that had been treated with CuPhe after channel 
activation (Fig. 7 C), suggesting that disulfide bond for-
mation had occurred under these conditions.
Both  K95C/I344C  and  Q98C/I344C  channel  cur-
rents were also potently inhibited by the addition of 
Cu
2+ ions alone (without phenanthroline) to the bath 
(Fig. 8). However, these effects were fully and easily re-
versed simply by washing the Cu
2+ ions from the bath 
(Fig. 8 A), indicating that inhibition by Cu
2+ was by a 
different mechanism than that by CuPhe. Each of the 
single mutants K95C, Q98C, and I344C showed reversible 
“paired”  mutants  with  one  cysteine  introduced  into 
each of TM1 (at K95 or Q98) and TM6 (at I344 and 
V345). Unfortunately, the double mutants K95C/V345C 
and Q98C/V345C did not yield functional currents 
when expressed in BHK cells, even after treatment with 
DTT to break any possible disulfide bonds; a similar 
lack of functional expression was previously reported 
for K95C/S341C (Zhou et al., 2010). However, K95C/
I344C, Q98C/I344C, and Q98C/M348C did generate 
macroscopic PKA- and ATP-dependent currents in inside-
out patches. These currents were not affected by the 
addition of 5 mM DTT to the intracellular solution 
(Fig. S2), suggesting that spontaneous disulfide bond 
formation between the two introduced cysteine side 
chains  is  either  negligible,  without  functional  conse-
quence, or cannot be reversed by DTT. However, the 
oxidizing agent CuPhe, which has previously been used 
to induce disulfide bond formation between introduced 
cysteines in other parts of the CFTR protein (Mense   
et al., 2006; Loo et al., 2008; Serohijos et al., 2008; Zhou 
et al., 2010), led to a strong reduction in current ampli-
tude in both K95C/I344C and Q98C/I344C (Fig. 6). 
Neither cys-less CFTR nor the single mutants K95C, 
Q98C, or I344C appeared sensitive to CuPhe under 
these conditions (Fig. 6 D), consistent with this agent 
acting by causing disulfide bond formation between the 
two introduced cysteine side chains in the double mu-
tants K95C/I344C and Q98C/I344C. Furthermore, the 
lack of effect of CuPhe on Q98C/M348C indicated that 
not all double-cysteine mutants were CuPhe sensitive, 
which we take to indicate that only nearby cysteine side 
chains can be cross-linked by this reagent. Inhibition of 
Figure 7.  Insensitivity to CuPhe before channel activation. (A and B) Example leak-subtracted I-V relationships for K95C/I344C (A) 
and Q98C/I344C (B) after channel activation with 20 nM PKA and 1 mM ATP in inside-out patches that had been pretreated with   
CuPhe for 2 min, and then washed to remove CuPhe. Currents were recorded before (control) and after (+DTT) the addition of 5 mM DTT 
to the cytoplasmic solution. (C) Mean effect of DTT on current amplitude in patches that had never seen CuPhe (no pretreatment), 
had been pretreated as in A and B (pretreatment CuPhe), or had been treated with CuPhe after channel activation (pretreatment   
CuPhe, PKA, ATP). In these experiments, an increase in current amplitude after DTT application is taken as evidence that disulfide bond 
formation had taken place. Asterisks indicate a significant difference from no pretreatment conditions (P < 0.05). Mean of data from 
three to six patches is shown in C.174 Three-dimensional organization of the CFTR pore
CFTR pore, and also contributes to interactions with 
cytoplasmic  open-channel  blocking  anions  (Linsdell, 
2005; Zhou et al., 2010). Cysteine introduced at this po-
sition has also previously been shown to be modified by 
MTS reagents (Akabas et al., 1994; Zhou et al., 2010). 
The importance of this residue in the normal Cl
 per-
meation  mechanism  is  demonstrated  by  the  finding 
that mutations that remove the positive charge at this 
position drastically reduce unitary Cl
 conductance (Ge 
et al., 2004; Zhou et al., 2010). Mutagenesis of Q98 (Ge 
et al., 2004) and P99 (Sheppard et al., 1996; Ge et al., 
2004) has also been shown to reduce unitary conduc-
tance. To our knowledge, the involvement of L102 has 
not previously been addressed by any mutagenesis study. 
At the outer end of TM1, another positively charged 
side chain, that of R104, is exposed to the extracellular 
solution where it acts to attract both Cl
 and blocking 
ions to the pore (Zhou et al., 2008). However, R104C 
was not sensitive to intracellularly applied MTS reagents 
(Figs. 1 and 2), consistent with the idea that such reagents 
are not able to permeate the CFTR pore (Alexander   
et al., 2009; El Hiani and Linsdell, 2010).
Our results concerning the accessibility of cysteines 
introduced into TM1 are summarized, and compared 
inhibition by Cu
2+ that was of intermediate potency 
between the cys-less background and the double mu-
tants K95C/I344C and Q98C/I344C. These results are 
consistent with the ability of metal ions such as Cu
2+ to 
bind reversibly to cysteine side chains (Lippard and 
Berg,  1994).  Nevertheless,  the  irreversible  effects  of   
CuPhe shown in Fig. 6 are clearly via a different mecha-
nism and apparently not contaminated by the reversible 
inhibitory effects of free Cu
2+ ions.
D I S C U S S I O N
Structure and orientation of TM1
Previous functional (Anderson et al., 1991; Sheppard   
et al., 1996; Ge et al., 2004; Linsdell, 2005; Zhou et al., 
2010) and substituted cysteine accessibility (Akabas et al., 
1994) work has suggested that TM1 lines the CFTR pore 
and contributes to pore functional properties. Consis-
tent with this, our present work shows that cysteines sub-
stituted for four different residues in TM1—K95, Q98, 
P99, and L102—are covalently modified by intracellu-
larly applied MTSES and MTSET (Figs. 1 and 2). The 
positively charged side chain of K95 is well known to be 
involved in electrostatic attraction of Cl
 ions to the 
Figure  8.  Reversible  inhibition  by 
cytoplasmic Cu
2+ ions. (A) Example 
leak-subtracted I-V relationships for 
cys-less  (left),  I344C  (center),  and 
Q98C/I344C  (right)  after  chan-
nel activation with 20 nM PKA and 
1 mM ATP. In each panel, currents 
are  shown  before  (control)  and 
after  the  addition  of  10  µM  Cu
2+ 
to  the  intracellular  solution.  In  all 
channel  constructs  studied,  these 
inhibitory effects of Cu
2+ were read-
ily and rapidly reversed by washing 
Cu
2+  from  the  bath  (for  example, 
see right panel for complete rever-
sal of the strong blocking effect on 
Q98C/I344C). (B) Mean fractional 
current  remaining  after  the  addi-
tion  of  different  concentrations  of 
Cu
2+ for cys-less (), I344C (), and 
Q98C/I344C (). Data are fitted as 
described in Materials and methods,   
giving Kd = 129 µM and nH = 1.36   
for cys-less, Kd = 19.5 µM and nH = 
1.21  for  I344C,  and  Kd  =  3.91  µM 
and  nH  =  1.65  for  Q98C/I344C.   
(C)  Mean Kd calculated from indi-
vidual patches using fits of the kind 
shown in B. Asterisks indicate a sig-
nificant difference from cys-less, and 
daggers indicate a significant differ-
ence between the double mutant in-
dicated and either of the individual 
mutations  alone  (P  <  0.05  in  each 
case).  Mean  of  data  from  four  to 
seven patches shown in B and C.  Wang et al. 175
parts of TM1 to the pore. In this model, TM6 appears to 
lie parallel to the central axis of the pore, whereas TM1 
appears bent, with its outer part lining the pore and its 
inner part pointing away from the pore and toward the 
outside of the membrane-spanning part of the CFTR 
protein (Mornon et al., 2008; Serohijos et al., 2008).
In open CFTR channels, internally applied MTS re-
agents can penetrate far enough into the pore as to 
modify L102C in TM1 and F337C in TM6. That MTS re-
agents are not permeant in CFTR (see above) suggests 
that some restriction in the open-channel pore prevents 
intracellularly applied MTS reagents from penetrating 
beyond these residues (Fig. 9). One possible explana-
tion is that these residues lie close to the narrowest part 
of the pore. Interestingly, amino acid side chains only 
one to two residues closer to the outer ends of these 
TMs, R104C in TM1 and I336C in TM6, can be modified 
by external, but not internal, MTS reagents (Fig. 9). Thus, 
in TM1 the cutoff between the “outside” and “inside” 
parts of the pore appears very distinct between L102 
and R104. In TM6, the boundary between outside and 
inside parts of the pore is less distinct, as there are three 
sites at which cysteine residues were found to be modified 
with our previous findings in TM6, in Fig. 9. Although 
both  of  these  TM  regions  appear  to  be  pore  lining, 
there are interesting differences in their apparent con-
tributions to the pore. First, only side chains in the outer 
part of TM1 are accessible to the pore lining in this 
model, whereas TM6 appears to contribute to the en-
tire length of the TM pore. Thus, cysteines substituted 
for Y84, G85, I86, F87, L88, Y89, L90, G91, V93, and 
T94, closer to the cytoplasmic end of TM1, were not 
modified  functionally  by  the  application  of  either   
MTSES or MTSET (Figs. 2 and S1). The simplest inter-
pretation of these negative results is that this part of TM1 
does not line the aqueous lumen of the pore. However, 
because our experiments measure the functional conse-
quences  of  MTS  modification,  rather  than  detecting 
modification directly by biochemical means, it is possi-
ble that modification of some side chains at the cyto-
plasmic end of TM1 does occur but is without functional 
effect. This might seem surprising, as MTS modification 
of the analogous part of TM6 has large effects on chan-
nel function that might reflect changes in both chan-
nel conductance and channel gating (Bai et al., 2010;   
El Hiani and Linsdell, 2010). Thus, if the cytoplasmic 
end of TM1 is accessible to cytoplasmic MTS reagents, 
the consistent lack of functional effect might mean 
that this part of TM1 is not closely associated with the 
permeation pathway for Cl
 ions. Second, whereas cys-
teines substituted for TM6 residues in the putative nar-
row pore region—F337C, T338C, and S341C—could 
be modified by both intracellular and extracellular MTS 
reagents (El Hiani and Linsdell, 2010), no residues that 
could be modified from both sides of the membrane 
were identified in TM1. Thus, the side chains of TM1 
mutants K95C, Q98C, P99C, and L102C that we identi-
fied  as  accessible  to  MTS  reagents  applied  from  the   
inside (Fig. 2) were not accessible to MTSET applied   
to the outside (Fig. 4), whereas R104C, previously 
shown to be modified by external MTS reagents (Zhou 
et al., 2008), was not modified by internal MTSES or 
MTSET (Fig. 2).
Clearly, TMs 1 and 6 make different overall contribu-
tions  to  the  pore,  with  TM1  apparently  contributing 
only to the outer part of the TM Cl
 permeation path-
way. It is possible that although some TMs (such as 
TM6) contribute to the entire length of the pore, the 
contribution of other TMs varies along the axis of the 
pore. For example, we previously suggested that TM5 
might make a greater functional contribution to the 
inner compared with the outer part of the pore (St. Aubin 
and Linsdell, 2006). Although it can be difficult to rec-
oncile functional data with current atomic models of 
the CFTR pore region (Bai et al., 2010; El Hiani and 
Linsdell, 2010; Zhou et al., 2010; see below), such a 
model that is based on homology modeling of the bac-
terial ABC protein Sav1866 may offer one potential ex-
planation for the differential contribution of different 
Figure 9.  Proposed locations of pore-lining side chains in TM1 
and TM6. Location of residues that, when mutated to cysteine, are 
exposed to intracellular MTS reagents only (blue), to extracellu-
lar MTS reagents only (green), or to MTS reagents applied to   
either side of the membrane (red) (see also El Hiani and Linsdell, 
2010). Other residues that we find not to be modified by intracel-
lular MTS reagents and are presumed to be non–pore lining are 
shown in black. For TM1 (left), internal MTS modification is as 
shown in Fig. 2; external MTS modification is as defined in Fig. 4  
or in previous work (Zhou et al., 2008). For TM6 (right), the 
model is as presented previously (El Hiani and Linsdell, 2010).176 Three-dimensional organization of the CFTR pore
a barrier exists inside the pore that prevents access   
of cytoplasmic substances in nonactivated channels   
(El Hiani and Linsdell, 2010). Although we have not inves-
tigated the state dependence of MTSES modification in 
TM1 in such great detail, our present results suggest a 
similar arrangement in which K95C can readily be mod-
ified before channel activation (Fig. 5), whereas Q98C, 
P99C, and L102C are modified rapidly after channel ac-
tivation (Fig. 3) but very slowly if at all before activation 
(Fig. 5). We would therefore speculatively suggest that 
K95, like TM6 residues V345 and M348, exists on the   
cytoplasmic side of the putative barrier inside the pore, 
whereas Q98, P99, and L102, like T338, S341, and I344 
in TM6, are located on the extracellular side of the bar-
rier (Fig. 9).
Alignment of TMs 1 and 6
The model we have developed in Fig. 9, based on the 
functional  effects  of  intracellular  MTS  reagents,  sug-
gests a relative alignment of pore-lining TMs 1 and 6. To 
test this proposed alignment functionally, we attempted 
to cross-link pore-lining cysteine side chains in these 
two TMs. Changes in channel function after the addi-
tion of the oxidizing agent CuPhe, that were not re-
versed by removal of this agent, were taken as evidence 
for the formation of a disulfide bridge between K95C in 
TM1 and I344C in TM6, and between Q98C in TM1 and 
I344C in TM6 (Fig. 6). Given that it is believed that the 
-carbon distance must be in the range of 5–8 Å for 
such disulfide bonds to form (Careaga and Falke, 1992), 
these results are consistent with close proximity of these 
pairs of pore-lining side chains in the three-dimensional 
structure of the pore. In contrast, we found no evidence 
for disulfide bond formation between a pair of intro-
duced cysteine side chains that would be predicted 
(based on Fig. 9) to be further apart, Q98C in TM1 and 
M348C in TM6 (Fig. 6, C and D). These data therefore 
add support to the model shown in Fig. 9 and, by sug-
gesting a close physical proximity of specific pore-lining 
amino acid side chains, extend this model of the CFTR 
pore into three dimensions. Furthermore, disulfide 
bond formation apparently required channel activation 
(Fig. 7), consistent with at least one of each pair of cys-
teine residues being located beyond the barrier and 
inaccessible to cytoplasmic reagents before channel 
activation (Fig. 9). The location of these putative neigh-
boring side chains in an atomic homology model of the 
CFTR TM region is shown in Fig. S3.
Introduction of pore-lining cysteine side chains also 
increased channel sensitivity to inhibition by Cu
2+ ions 
(Fig.  8).  Although  this  is  consistent  with  the  known 
metal-binding  properties  of  cysteine  side  chains,  the 
completely reversible nature of inhibition by even high 
concentrations of Cu
2+ (Fig. 8) indicates that this inhibi-
tory effect did not contribute to the inhibitory effects of 
CuPhe (Fig. 6).
by MTS reagents applied to either side of the mem-
brane using approaches similar to those used in the 
present study (El Hiani and Linsdell, 2010) (Fig. 9). 
Currently, it is not clear why there are no sites in TM1 
that can be accessed from both sides of the membrane 
in our hands (although it should be noted that Q98C 
was described as being sensitive to external MTSES in   
a previous study; Akabas et al., 1994). One possibility 
raised previously (El Hiani and Linsdell, 2010) is that 
TM6 undergoes some conformational change that al-
lows it to be accessible to the outside in one conforma-
tion  and  the  inside  in  another  conformation.  If  this 
were the case, it would have to be postulated that TM1 
does not show similar conformational movements, an-
other potential functional difference between these two 
pore-forming helices.
The  MTS  reagent  modification  rate  constant  was 
greater for cysteines introduced closer to the intracellu-
lar end of TM1 (Fig. 3), suggesting that, even in open 
channels, some obstacle restricts the access of intracel-
lular MTS reagents into the deeper reaches of the pore. 
A similar restriction to MTSES modification was seen in 
TM6 (El Hiani and Linsdell, 2010) and was proposed to 
represent a physical narrowing of the pore lumen. For 
comparison, the MTSES modification rate constant for 
P99C and L102C (Fig. 3) was similar to that of T338C 
and S341C in TM6 (El Hiani and Linsdell, 2010) (all 
between 100 and 150 M
1 s
1), and the modification 
rate constant for K95C was comparable to, or slightly 
greater than, that of I344C, V345C, and M348C (El Hiani 
and Linsdell, 2010) (all between 2,000 and 4,000 M
1 s
1). 
These two “groups” of residues coming from two dif-
ferent TMs may therefore exist at regions inside the 
pore with approximately equivalent access to cytoplas-
mic MTSES (Fig. 9). The MTSES modification rate con-
stant for Q98C (440 M
1 s
1; Fig. 3) was somewhat 
intermediate between these two groups. Interestingly, 
at each site investigated in TM1, the modification rate 
constant for MTSET was consistently 8–13-fold lower 
than that for MTSES (Fig. 3). Because MTSES and   
MTSET are similar molecules, the most likely explana-
tion for this difference in modification rate constant is 
that access to the anion-selective CFTR pore from the 
cytoplasm is easier for negatively charged MTSES than 
for positively charged MTSET. If this is the case, the 
similar discrepancy between MTSES and MTSET modi-
fication rate constants at all sites tested implies that the 
location of anion–cation discrimination that underlies 
this discrepancy may lie between the cytoplasmic mouth 
of the pore and the most accessible cysteine residue, 
namely, that at K95C. It has previously been suggested 
that the cytoplasmic mouth of the CFTR pore is a site 
that  determines  anion–cation  selectivity  (Guinamard 
and Akabas, 1999).
Previous work investigating state-dependent access of 
MTSES to cysteines introduced into TM6 suggested that   Wang et al. 177
of two important pore-lining TMs. This kind of informa-
tion is necessary to develop and validate three-dimensional 
structural models of the pore region. Previously, we showed 
that a disulfide bond could be formed between K95C (in 
TM1) and S1141C (in TM12) (Zhou et al., 2010). Cysteine 
side chains can also be cross-linked between residues at 
the  cytoplasmic  ends  of  TM6  and  TM12  (Chen  et  al., 
2004), as well as between I340C (TM6) and S877C (TM7) 
(Wang et al., 2007); however, these findings are more diffi-
cult to interpret in structural terms because longer cross-
linking molecules were used, and also because the side 
chain of I340C is not accessible to the aqueous lumen of 
the pore (Bai et al., 2010; El Hiani and Linsdell, 2010). 
Our present results suggest that both TM1 and TM6 con-
tribute to the outer part of the pore and, at least at the 
level of K95/Q98/I344, come into close enough contact 
for disulfide bond formation to take place across the   
lumen of the pore (Figs. 9 and S3). In contrast, TM1   
appears not to contribute to the inner part of the pore 
(Fig. 9), perhaps because this TM bends away from the 
central axis of the pore. Thus, the relative contribution of 
different TMs can vary along the length of the pore.
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